<DOC>
	<DOC>NCT02145234</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of single and multiple doses of BMS-986089 in healthy adult subjects.</brief_summary>
	<brief_title>Placebo-Controlled, Single and Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986089 in Healthy Adult Subjects</brief_title>
	<detailed_description>Primary Purpose - other: Protocol designed to assess the safety, tolerability, immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BMS-986089 in healthy subjects Enrollment: Single ascending dose panels: 48 subjects, Multiple ascending dose panels: 96 Minimum age: 18 years (Elderly MAD Panel 65 years of age) Maximum age: 55 years (Elderly MAD Panel 70 years of age)</detailed_description>
	<criteria>For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com Healthy subjects as determined by no clinically significant deviation from normal medical history, physical examination, ECGs and clinical laboratory determinations Men and women who are not of childbearing potential (ie, who are postmenopausal or Surgically sterile WOCBP) ages 21 to 55 years Women must not be breastfeeding Men who are sexually active with women of child bearing potential (WOCBP) must use any contraceptive method with a failure rate of less than 1% per year Any significant acute or chronic medical illness Any major surgery within 6 weeks of study drug administration Any condition that will clearly require medical or surgical treatment during the period of study participation Any bone trauma or bone surgery within 3 months of study drug administration Known or suspected autoimmune disorder Donation of blood or plasma to a blood bank or in a clinical study (except at screening visit) within 6 weeks of study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>